{
  "DOI": "10.1007/s10689-013-9646-7",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-013-9646-7",
  "alternative-id": [
    "9646"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Plakhins",
      "given": "Grigorijs",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Irmejs",
      "given": "Arvids",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gardovskis",
      "given": "Andris",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Subatniece",
      "given": "Signe",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Liepniece-Karele",
      "given": "Inta",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Purkalne",
      "given": "Gunta",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Teibe",
      "given": "Uldis",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Trofimovics",
      "given": "Genadijs",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Miklasevics",
      "given": "Edvins",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gardovskis",
      "given": "Janis",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2013,
        5,
        2
      ]
    ],
    "date-time": "2013-05-02T16:40:37Z",
    "timestamp": 1367512837000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:11Z",
    "timestamp": 1559252771000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        7,
        13
      ]
    ],
    "date-time": "2023-07-13T13:31:15Z",
    "timestamp": 1689255075715
  },
  "is-referenced-by-count": 8,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2013,
        5,
        3
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2013,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2013,
            5,
            3
          ]
        ],
        "date-time": "2013-05-03T00:00:00Z",
        "timestamp": 1367539200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9646-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-013-9646-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9646-7",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "683-689",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2013,
        5,
        3
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2013,
        5,
        3
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2013,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(05)66544-0",
      "author": "Early Breast Cancer Trialists’ Collaborative Group",
      "doi-asserted-by": "crossref",
      "first-page": "1687",
      "issue": "9472",
      "journal-title": "Lancet.",
      "key": "9646_CR1",
      "unstructured": "Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 365(9472):1687–1717",
      "volume": "365",
      "year": "2005"
    },
    {
      "DOI": "10.1093/annonc/mdr371",
      "author": "S Aebi",
      "doi-asserted-by": "crossref",
      "first-page": "vi12",
      "issue": "Suppl 6",
      "journal-title": "Ann Oncol",
      "key": "9646_CR2",
      "unstructured": "Aebi S, Davidson T, Gruber G, Cardoso F, ESMO Guidelines Working Group (2011) Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 22(Suppl 6):vi12–vi24",
      "volume": "22",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nrclinonc.2010.170",
      "author": "C Oakman",
      "doi-asserted-by": "crossref",
      "first-page": "725",
      "issue": "12",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "9646_CR3",
      "unstructured": "Oakman C, Santarpia L, Di Leo A (2010) Breast cancer assessment tools and optimizing adjuvant therapy. Nat Rev Clin Oncol 7(12):725–732",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2005.06.178",
      "author": "IA Olivotto",
      "doi-asserted-by": "crossref",
      "first-page": "2716",
      "issue": "12",
      "journal-title": "J Clin Oncol",
      "key": "9646_CR4",
      "unstructured": "Olivotto IA, Bajdik CD, Ravdin PM, Speers CH, Coldman AJ, Norris BD, Davis GJ, Chia SK, Gelmon KA (2005) Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 23(12):2716–2725",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.ejso.2011.02.001",
      "author": "GC Wishart",
      "doi-asserted-by": "crossref",
      "first-page": "411",
      "issue": "5",
      "journal-title": "Eur J Surg Oncol",
      "key": "9646_CR5",
      "unstructured": "Wishart GC, Bajdik CD, Azzato EM, Dicks E, Greenberg DC, Rashbass J, Caldas C, Pharoah PD (2011) A population-based validation of the prognostic model PREDICT for early breast cancer. Eur J Surg Oncol 37(5):411–417",
      "volume": "37",
      "year": "2011"
    },
    {
      "DOI": "10.1038/sj.bjc.6605283",
      "doi-asserted-by": "crossref",
      "key": "9646_CR6",
      "unstructured": "Campbell HE, Taylor MA, Harris AL, Gray AM (2009) An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom. Br J Cancer 101(7):1074–1084"
    },
    {
      "DOI": "10.1016/S1470-2045(09)70254-2",
      "author": "S Mook",
      "doi-asserted-by": "crossref",
      "first-page": "1070",
      "issue": "11",
      "journal-title": "Lancet Oncol",
      "key": "9646_CR7",
      "unstructured": "Mook S, Schmidt MK, Rutgers EJ, van de Velde AO, Visser O, Rutgers SM, Armstrong N, van’t Veer LJ, Ravdin PM (2009) Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study. Lancet Oncol 10(11):1070–1076",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1371/journal.pone.0027446",
      "author": "D Hajage",
      "doi-asserted-by": "crossref",
      "first-page": "e27446",
      "issue": "11",
      "journal-title": "PLoS ONE",
      "key": "9646_CR8",
      "unstructured": "Hajage D, de Rycke Y, Bollet M, Savignoni A, Caly M, Pierga JY, Horlings HM, Van de Vijver MJ, Vincent-Salomon A, Sigal-Zafrani B, Senechal C, Asselain B, Sastre X, Reyal F (2011) External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement. PLoS ONE 6(11):e27446 (Epub 2011 Nov 8)",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ejca.2012.01.034",
      "author": "N Bhoo-Pathy",
      "doi-asserted-by": "crossref",
      "first-page": "982",
      "issue": "7",
      "journal-title": "Eur J Cancer",
      "key": "9646_CR9",
      "unstructured": "Bhoo-Pathy N, Yip CH, Hartman M, Saxena N, Taib NA, Ho GF, Looi LM, Bulgiba AM, Graaf Y, Verkooijen HM (2012) Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients. Eur J Cancer 48(7):982–989",
      "volume": "48",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.molonc.2010.04.011",
      "author": "N Mavaddat",
      "doi-asserted-by": "crossref",
      "first-page": "174",
      "issue": "3",
      "journal-title": "Mol Oncol",
      "key": "9646_CR10",
      "unstructured": "Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M (2010) Genetic susceptibility to breast cancer. Mol Oncol 4(3):174–191",
      "volume": "4",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2010.33.0068",
      "author": "PJ Goodwin",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "issue": "1",
      "journal-title": "J Clin Oncol",
      "key": "9646_CR11",
      "unstructured": "Goodwin PJ, Phillips KA, West DW, Ennis M, Hopper JL, John EM, O’Malley FP, Milne RL, Andrulis IL, Friedlander ML, Southey MC, Apicella C, Giles GG, Longacre TA (2012) Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an international prospective breast cancer family registry population-based cohort study. J Clin Oncol 30(1):19–26",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1056/NEJMoa070608",
      "author": "G Rennert",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "issue": "2",
      "journal-title": "N Engl J Med",
      "key": "9646_CR12",
      "unstructured": "Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, Narod SA (2007) Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357(2):115–123",
      "volume": "357",
      "year": "2007"
    },
    {
      "DOI": "10.1186/bcr658",
      "author": "ME Robson",
      "doi-asserted-by": "crossref",
      "first-page": "R8",
      "issue": "1",
      "journal-title": "Breast Cancer Res",
      "key": "9646_CR13",
      "unstructured": "Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Bégin LR, Offit K (2004) Foulkes WD A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 6(1):R8–R17",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1186/bcr748",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "E7",
      "issue": "1",
      "journal-title": "Breast Cancer Res",
      "key": "9646_CR14",
      "unstructured": "Evans DG, Howell A (2004) Are BRCA1- and BRCA2-related breast cancers associated with increased mortality? Breast Cancer Res 6(1):E7",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1186/1471-2350-12-147",
      "author": "G Plakhins",
      "doi-asserted-by": "crossref",
      "first-page": "147",
      "issue": "12",
      "journal-title": "BMC Med Genet",
      "key": "9646_CR15",
      "unstructured": "Plakhins G, Irmejs A, Gardovskis A, Subatniece S, Rozite S, Bitina M, Keire G, Purkalne G, Teibe U, Trofimovics G, Miklasevics E, Gardovskis J (2011) Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia. BMC Med Genet 27(12):147",
      "volume": "27",
      "year": "2011"
    },
    {
      "DOI": "10.1186/bcr2464",
      "author": "GC Wishart",
      "doi-asserted-by": "crossref",
      "first-page": "R1",
      "issue": "1",
      "journal-title": "Breast Cancer Res",
      "key": "9646_CR16",
      "unstructured": "Wishart GC, Azzato EM, Greenberg DC, Rashbass J, Kearins O, Lawrence G, Caldas C, Pharoah PD (2010) PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res 12(1):R1",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2001.19.4.980",
      "author": "PM Ravdin",
      "doi-asserted-by": "crossref",
      "first-page": "980",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "9646_CR17",
      "unstructured": "Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N, Parker HL (2001) Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19(4):980–991",
      "volume": "19",
      "year": "2001"
    },
    {
      "key": "9646_CR18",
      "unstructured": "Adjuvant! Breast Cancer Help files. https://www.adjuvantonline.com/breasthelp0306/breastindex.html"
    },
    {
      "key": "9646_CR19",
      "unstructured": "http://www.predict.nhs.uk/technical.shtml"
    },
    {
      "DOI": "10.1038/bjc.2012.338",
      "doi-asserted-by": "crossref",
      "key": "9646_CR20",
      "unstructured": "Wishart GC, Bajdik CD, Dicks E, Provenzano E, Schmidt MK et al. (2012) PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. Br J Cancer 107: 800–807"
    },
    {
      "DOI": "10.1016/j.clon.2010.11.004",
      "author": "V Agarwal",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "issue": "2",
      "journal-title": "Clin Oncol (R Coll Radiol)",
      "key": "9646_CR21",
      "unstructured": "Agarwal V, O’Neill P (2011) Adjuvant! Online as a decision-making tool in early breast cancer-a UK national survey. Clin Oncol (R Coll Radiol) 23(2):159–160",
      "volume": "23",
      "year": "2011"
    },
    {
      "DOI": "10.1002/pon.1040",
      "author": "LA Siminoff",
      "doi-asserted-by": "crossref",
      "first-page": "1001",
      "issue": "11",
      "journal-title": "Psychooncology",
      "key": "9646_CR22",
      "unstructured": "Siminoff LA, Gordon NH, Silverman P, Budd T, Ravdin PM (2006) A decision aid to assist in adjuvant therapy choices for breast cancer. Psychooncology 15(11):1001–1013",
      "volume": "15",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s10549-009-0566-z",
      "author": "L Bordeleau",
      "doi-asserted-by": "crossref",
      "first-page": "13",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9646_CR23",
      "unstructured": "Bordeleau L, Panchal S, Goodwin P (2010) Prognosis of BRCA-associated breast cancer: a summary of evidence. Breast Cancer Res Treat 119(1):13–24",
      "volume": "119",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10549-011-1711-z",
      "author": "S Bayraktar",
      "doi-asserted-by": "crossref",
      "first-page": "145",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9646_CR24",
      "unstructured": "Bayraktar S, Gutierrez-Barrera AM, Liu D, Tasbas T, Akar U, Litton JK, Lin E, Albarracin CT, Meric-Bernstam F, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK (2011) Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations. Breast Cancer Res Treat 130(1):145–153",
      "volume": "130",
      "year": "2011"
    },
    {
      "DOI": "10.1136/jmg.39.8.608",
      "author": "PO Chappuis",
      "doi-asserted-by": "crossref",
      "first-page": "608",
      "issue": "8",
      "journal-title": "J Med Genet",
      "key": "9646_CR25",
      "unstructured": "Chappuis PO, Goffin J, Wong N, Perret C, Ghadirian P, Tonin PN, Foulkes WD (2002) A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer. J Med Genet 39(8):608–610",
      "volume": "39",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2008.20.7019",
      "author": "T Byrski",
      "doi-asserted-by": "crossref",
      "first-page": "375",
      "issue": "3",
      "journal-title": "J Clin Oncol",
      "key": "9646_CR26",
      "unstructured": "Byrski T, Gronwald J, Huzarski T, Grzybowska E, Budryk M, Stawicka M, Mierzwa T, Szwiec M, Wisniowski R, Siolek M, Dent R, Lubinski J, Narod S (2010) Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. J Clin Oncol 28(3):375–379",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10549-013-2429-x",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "273",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9646_CR27",
      "unstructured": "Narod SA, Metcalfe K, Lynch HT, Ghadirian P, Robidoux A, Tung N, Gaughan E, Kim-Sing C, Olopade OI, Foulkes WD, Robson M, Offit K, Jakubowska A, Byrski T, Huzarski T, Sun P, Lubinski J (2013) Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy? Breast Cancer Res Treat 138(1):273–279",
      "volume": "138",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.2007.15.0235",
      "author": "P Rastogi",
      "doi-asserted-by": "crossref",
      "first-page": "778",
      "issue": "5",
      "journal-title": "J Clin Oncol",
      "key": "9646_CR28",
      "unstructured": "Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil SR, Tamkus D, King KM, Pajon ER, Wright MJ, Robert J, Paik S, Mamounas EP, Wolmark N (2008) Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. J Clin Oncol 26(5):778–785",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1186/1472-6874-10-28",
      "author": "M Salhab",
      "doi-asserted-by": "crossref",
      "first-page": "28",
      "journal-title": "BMC Women’s Health",
      "key": "9646_CR29",
      "unstructured": "Salhab M, Bismohun S, Mokbel K (2010) Risk-reducing strategies for women carrying brca1/2 mutations with a focus on prophylactic surgery. BMC Women’s Health 10:28",
      "volume": "10",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2004.04.188",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1055",
      "issue": "6",
      "journal-title": "J Clin Oncol",
      "key": "9646_CR30",
      "unstructured": "Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, Van ‘t Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10549-009-0685-6",
      "author": "YM Kirova",
      "doi-asserted-by": "crossref",
      "first-page": "119",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9646_CR31",
      "unstructured": "Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A (2010) Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature. Breast Cancer Res Treat 120(1):119–126",
      "volume": "120",
      "year": "2010"
    },
    {
      "DOI": "10.1097/PPO.0b013e318238f579",
      "author": "KL Smith",
      "doi-asserted-by": "crossref",
      "first-page": "492",
      "issue": "6",
      "journal-title": "Cancer J",
      "key": "9646_CR32",
      "unstructured": "Smith KL, Isaacs C (2011) BRCA mutation testing in determining breast cancer therapy. Cancer J 17(6):492–499",
      "volume": "17",
      "year": "2011"
    }
  ],
  "reference-count": 32,
  "references-count": 32,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-013-9646-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients"
  ],
  "type": "journal-article",
  "volume": "12"
}